北京大学学报(医学版) ›› 2020, Vol. 52 ›› Issue (5): 836-844. doi: 10.19723/j.issn.1671-167X.2020.05.007
Xiao-zhen LIU,Ying-ying LI,Li-ping YANG()
摘要:
目的:对比外显子组测序(whole exome sequencing,WES)和目标序列靶向捕获测序检测中国遗传性视网膜变性(inherited retinal dystrophies,IRDs)患者致病基因变异的差异。方法:收集182例IRDs家系,所有先证者均接受系统的眼科检查和必要的全身检查,采集患者及家属血样并提取基因组DNA。按照就诊的时间顺序将患者平均分为两组,一组91例接受WES,另一组91例应用本课题组设计并定制的“遗传性眼病基因诊断芯片” (hereditary eye disease enrichment panel,HEDEP)进行IRDs致病基因外显子区域靶向捕获测序。对候选致病基因用Sanger测序进行验证,并对家系成员进行共分离分析,使用多重连接依赖的探针扩增技术对拷贝数变异进行验证,针对二代测序捕获效率低的区域如RPGR ORF15区,应用Sanger 测序补充检测。根据美国医学遗传学与基因组学学会和分子病理学协会(American College of Medical Genetics and Genomics and the Association for Molecular Pathology,ACMG/AMP)制定的《ACMG/AMP基因变异分类标准与指南》将检测到的所有基因变异进行分类,本文只包含“致病的”、“可能致病的”的基因变异,不包含“意义不明确的”、“可能良性的”和“良性的”基因变异。结果:应用HEDEP确诊的家系共51例,阳性率为56.04%(51/91);应用WES确诊的家系共30例,阳性率为33.00%(30/91);总阳性率44.51%(81/182)。平均测序深度以及测序覆盖度方面,HEDEP优于WES,此外HEDEP具有检测拷贝数变异潜力。本研究共检测到29个IRDs基因的致病突变,最常见的致病基因为USH2A、ABCA4和RPGR,基因突变频率分别为11.54%(21/182)、6.59%(12/182)、3.85%(7/182);共发现43个新的致病突变,并检测到6例家系携带RPGR ORF15区的突变。结论:针对临床确诊的IRDs病例,HEDEP较WES能获得更高的基因诊断阳性率和更精确的诊断结果,可作为IRDs基因诊断的首选方法,WES可作为其他基因诊断方法的补充手段。同时,本研究丰富了IRDs致病基因的突变频谱,为将来IRDs基因诊断、遗传咨询和基因治疗奠定了基础。
中图分类号:
[1] |
Berger W, Kloeckener-Gruissem B, Neidhardt J. The molecular basis of human retinal and vitreoretinal diseases[J]. Prog Retin Eye Res, 2010,29(5):335-375.
doi: 10.1016/j.preteyeres.2010.03.004 |
[2] |
Zhao L, Wang F, Wang H, et al. Next-generation sequencing-based molecular diagnosis of 82 retinitis pigmentosa probands from Northern Ireland[J]. Hum Genet, 2015,134(2):217-230.
doi: 10.1007/s00439-014-1512-7 pmid: 25472526 |
[3] |
Glockle N, Konl LS, Mohr J, et al. Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies[J]. Eur J Hum Genet, 2014,22(1):99-104.
doi: 10.1038/ejhg.2013.72 |
[4] | Beryozkin A, Shevah E, Kimchi A, et al. Whole exome sequencing reveals mutations in known retinal disease genes in 33 out of 68 Israeli families with inherited retinopathies[J]. Sci Rep, 2015(5):13187. |
[5] |
Yang L, Cui H, Yin X, et al. Dependable and efficient clinical molecular diagnosis of Chinese RP patient with targeted exon sequencing[J]. PLoS One, 2015,10(10):e0140684.
doi: 10.1371/journal.pone.0140684 pmid: 26496393 |
[6] | Riera M, Navarro R, Ruiz-Nogales S, et al. Whole exome sequencing using Ion Proton system enables reliable genetic diagnosis of inherited retinal dystrophies[J]. Sci Rep, 2017(7):42078. |
[7] |
Zhang J, Wang C, Shen Y, et al. A mutation in ADIPOR1 causes nonsyndromic autosomal dominant retinitis pigmentosa[J]. Hum Genet, 2016,135(12):1375-1387.
doi: 10.1007/s00439-016-1730-2 pmid: 27655171 |
[8] |
Bader I, Brandau O, Achatz H, et al. X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15[J]. Invest Ophthalmol Vis Sci, 2003,44(4):1458-1463.
doi: 10.1167/iovs.02-0605 pmid: 12657579 |
[9] |
Li L, Xiao X, Li S, et al. Detection of variants in 15 genes in 87 unrelated Chinese patients with Leber congenital amaurosis[J]. PLoS One, 2011,6(5):e19458.
doi: 10.1371/journal.pone.0019458 pmid: 21602930 |
[10] |
Xiao X, Mai G, Li S, et al. Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy[J]. Biochem Biophys Res Commun, 2011,409(2):181-186.
doi: 10.1016/j.bbrc.2011.04.112 pmid: 21565171 |
[11] |
Li A, Jiao X, Munier FL, et al. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2[J]. Am J Hum Genet, 2004,74(5):817-826.
doi: 10.1086/383228 |
[12] |
Consugar MB, Navarro-Gomez D, Place EM, et al. Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing[J]. Genet Med, 2015,17(4):253-261.
doi: 10.1038/gim.2014.172 pmid: 25412400 |
[13] |
Bujakowska KM, Fernandez-Godino R, Place E, et al. Copy-number variation is an important contributor to the genetic causality of inherited retinal degenerations[J]. Genet Med, 2017,19(6):643-651.
doi: 10.1038/gim.2016.158 pmid: 27735924 |
[14] |
Haer-Wigman L, van Zelst-Stams WA, Pfundt R, et al. Diagnostic exome sequencing in 266 Dutch patients with visual impairment[J]. Eur J Hum Genet, 2017,25(5):591-599.
doi: 10.1038/ejhg.2017.9 pmid: 28224992 |
[15] | Broadgate S, Yu J, Downes SM, et al. Unravelling the genetics of inherited retinal dystrophies: Past, present and future[J]. Prog Retin Eye Res, 2017(59):53-96. |
[16] | 周雪莹, 于志强. 全基因组外显子测序在眼科遗传病中的应用[J]. 中华眼科杂志, 2015,51(5):395-400. |
[17] |
ACMG Board of Directors Points to consider in the clinical application of genomic sequencing[J]. Genet Med, 2012,14(8):759-761.
doi: 10.1038/gim.2012.74 pmid: 22863877 |
[18] |
Yuzawa M, Mae Y, Matsui M. Bietti’s crystalline retinopathy[J]. Ophthalmic Paediatr Genet, 1986,7(1):9-20.
doi: 10.3109/13816818609058037 pmid: 3703493 |
[19] |
Lee KY, Koh AH, Aung T, et al. Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations[J]. Invest Ophthalmol Vis Sci, 2005,46(10):3812-3816.
pmid: 16186368 |
[20] |
Tiwari A, Lemke J, Altmueller J, et al. Identification of novel and recurrent disease-causing mutations in retinal dystrophies using whole exome sequencing (WES): Benefits and limitations[J]. PLoS One, 2016,11(7):e0158692.
doi: 10.1371/journal.pone.0158692 pmid: 27391102 |
[1] | 谢尚,蔡志刚,单小峰. 全外显子测序及相关指标在口腔鳞状细胞癌精准治疗中的应用价值[J]. 北京大学学报(医学版), 2023, 55(4): 697-701. |
[2] | 冯科,倪菁菁,夏彦清,曲晓伟,张慧娟,万锋,洪锴,张翠莲,郭海彬. 3例SUN5基因变异导致无头精子症的遗传学分析和助孕治疗结局[J]. 北京大学学报(医学版), 2021, 53(4): 803-807. |
[3] | 李芳,刘洋,刘浩辰,冯海兰. 乳光牙本质患者的基因变异分析及患牙的组织学观察[J]. 北京大学学报(医学版), 2018, 50(4): 666-671. |
[4] | 吴恺,张杨,张红,檀增桓,郭晓蕙,杨建梅. 嗜铬细胞瘤/副神经节瘤患者RET、VHL、SDHD、SDHB遗传基因变异的检测[J]. 北京大学学报(医学版), 2018, 50(4): 634-639. |
|